Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel D Miller

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Seminars in Cutaneous Medicine and Surgery|September 9, 2016
Histopathology of vascular anomalies: update based on the revised 2014 ISSVA classificationDaniel D Miller, Anita Gupta
The American Journal of Dermatopathology|August 16, 2012
Bullous tinea pedis with direct immunofluorescence positivity: when is a positive result not autoimmune bullous disease?Daniel D Miller, Jag Bhawan
Dermatitis : Contact, Atopic, Occupational, Drug|February 17, 2007
Adverse cutaneous reactions to antimicrobials in patients with human immunodeficiency virus infectionDaniel D Miller, Erin M Warshaw
Journal of Cutaneous Pathology|June 11, 2009
Pustular porokeratosisDaniel D Miller, Beth S Ruben
Seminars in Cutaneous Medicine and Surgery|March 2, 2017
The role of dermatopathology in inpatient careCuong V Nguyen, Daniel D Miller
Journal of Cutaneous Pathology|November 19, 2016
Serum sickness-like drug reaction: two cases with a neutrophilic urticarial patternCuong V Nguyen, Daniel D Miller
Pediatric Dermatology|August 5, 2019
Diffuse, mottled hyperpigmentation and mutations in LMNA gene in a 5-year-old boy, his mother, and his grandmother: Atypical progeroid syndromeBrittney Schultz, Daniel D Miller, Sheilagh Maguiness
The American Journal of Dermatopathology|May 8, 2014
Cutaneous malignant melanoma: update on diagnostic and prognostic biomarkersOssama Abbas, Daniel D Miller, Jag Bhawan
JAAD Case Reports|March 20, 2026
Sporotrichoid presentation of rubella-associated granulomatous dermatitisJessica Padniewski, Daniel D Miller, Eamonn Maher
Drugs in R&D|June 14, 2024
PD-1 Inhibitor Induced Hypertrophic Lichen Planus: A Case ReportOlivia Lim, Eamonn Maher, Daniel D Miller
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Seminars in Cutaneous Medicine and Surgery|September 9, 2016
Histopathology of vascular anomalies: update based on the revised 2014 ISSVA classificationDaniel D Miller, Anita Gupta
The American Journal of Dermatopathology|August 16, 2012
Bullous tinea pedis with direct immunofluorescence positivity: when is a positive result not autoimmune bullous disease?Daniel D Miller, Jag Bhawan
Dermatitis : Contact, Atopic, Occupational, Drug|February 17, 2007
Adverse cutaneous reactions to antimicrobials in patients with human immunodeficiency virus infectionDaniel D Miller, Erin M Warshaw
Journal of Cutaneous Pathology|June 11, 2009
Pustular porokeratosisDaniel D Miller, Beth S Ruben
Seminars in Cutaneous Medicine and Surgery|March 2, 2017
The role of dermatopathology in inpatient careCuong V Nguyen, Daniel D Miller
Journal of Cutaneous Pathology|November 19, 2016
Serum sickness-like drug reaction: two cases with a neutrophilic urticarial patternCuong V Nguyen, Daniel D Miller
Pediatric Dermatology|August 5, 2019
Diffuse, mottled hyperpigmentation and mutations in LMNA gene in a 5-year-old boy, his mother, and his grandmother: Atypical progeroid syndromeBrittney Schultz, Daniel D Miller, Sheilagh Maguiness
The American Journal of Dermatopathology|May 8, 2014
Cutaneous malignant melanoma: update on diagnostic and prognostic biomarkersOssama Abbas, Daniel D Miller, Jag Bhawan
JAAD Case Reports|March 20, 2026
Sporotrichoid presentation of rubella-associated granulomatous dermatitisJessica Padniewski, Daniel D Miller, Eamonn Maher
Drugs in R&D|June 14, 2024
PD-1 Inhibitor Induced Hypertrophic Lichen Planus: A Case ReportOlivia Lim, Eamonn Maher, Daniel D Miller
Pageof 5